Cryo-Cell International is a cellular preservation company specializing in the collection, processing, and cryogenic storage of umbilical cord blood and cord tissue stem cells for private family banking, as well as public cord blood inventory distribution. The company operates three main business segments: private cord blood and tissue storage (generating revenue from processing fees, annual storage fees, and pre-paid multi-year contracts); public cord blood banking through a regulated inventory distributed to transplant centers; and manufacturing the PrepaCyte CB Processing System, an FDA-cleared medical device for automated cord blood processing. Additional revenue streams include third-party biorepository services and international affiliate licensing fees. Cryo-Cell serves expectant parents, physicians, and healthcare facilities seeking to preserve stem cells for potential future regenerative and transplant therapies, competing in a niche market where cord blood banking remains significantly under-penetrated despite growing clinical applications.